• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis.评估血浆或血清对尿激酶激活的纤维蛋白溶解抑制作用的方法。
J Clin Pathol. 1966 May;19(3):233-7. doi: 10.1136/jcp.19.3.233.
2
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
3
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.纤溶酶原激活剂的纤维蛋白特异性影响纤维蛋白溶解效率及对超声的反应性:九种纤溶酶原激活剂的体外比较
Thromb Haemost. 1999 Apr;81(4):605-12.
4
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
5
Partial purification and properties of a plasminogen activator from human erythrocytes.人红细胞纤溶酶原激活剂的部分纯化及性质
J Clin Invest. 1969 Oct;48(10):1777-85. doi: 10.1172/JCI106144.
6
Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.体外或溶栓治疗期间纤溶酶原的消耗会限制纤溶潜力。
J Lab Clin Med. 1992 Jul;120(1):120-8.
7
Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.重组人C1抑制剂在最佳纤维蛋白溶解过程中可防止突变型尿激酶原引起的非特异性蛋白水解。
Thromb Haemost. 2009 Aug;102(2):279-86. doi: 10.1160/TH08-09-0598.
8
In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.豚鼠角膜细胞组织型纤溶酶原激活剂的纤溶、溶栓和纤维蛋白原溶解特性的体外研究。
Thromb Haemost. 1985 Apr 22;53(2):200-3.
9
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.凝血酶激活的纤溶抑制物(TAFI)以纤溶酶原激活物浓度依赖的方式影响纤维蛋白溶解。在内源性凝块溶解模型中对七种纤溶酶原激活物的研究。
Thromb Haemost. 2004 Mar;91(3):473-9. doi: 10.1160/TH03-06-0377.
10
Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.活化的因子 XII 使纤溶酶原激活物抑制剂 1 失活,在体外接触因子增强纤维蛋白溶解过程中发挥作用。
Life Sci. 2009 Jul 31;85(5-6):220-5. doi: 10.1016/j.lfs.2009.05.014. Epub 2009 Jun 3.

引用本文的文献

1
Effect of age, sex, and diurnal variation on the human fibrinolystic system.年龄、性别和昼夜变化对人体纤维蛋白溶解系统的影响。
J Clin Pathol. 1967 May;20(3):223-6. doi: 10.1136/jcp.20.3.223.

本文引用的文献

1
A method for determining serum inhibitors of plasminogen activation.一种测定纤溶酶原激活血清抑制剂的方法。
Scand J Clin Lab Invest. 1962;14:138-44. doi: 10.3109/00365516209079685.
2
ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.纤维蛋白溶解抑制剂在肝硬化中的作用。
Lancet. 1964 Nov 7;2(7367):990-1. doi: 10.1016/s0140-6736(64)90933-x.
3
THE EFFECT OF CALCIUM OF FIBRINOLYSIS IN VITRO.钙对体外纤维蛋白溶解的影响。
J Clin Pathol. 1964 May;17(3):282-6. doi: 10.1136/jcp.17.3.282.
4
Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system.一名年轻男性患有严重血栓性疾病,伴有骨髓和骨骼改变,且纤溶系统中一种抑制剂含量较高。
Acta Med Scand. 1961 Mar;169:323-37. doi: 10.1111/j.0954-6820.1961.tb07838.x.
5
An evaluation of the euglobulin method for the determination of fibrinolysis.优球蛋白法测定纤维蛋白溶解的评估。
J Clin Pathol. 1959 May;12(3):215-8. doi: 10.1136/jcp.12.3.215.
6
Studies on enhanced fibrinolytic activity in man.关于人类纤维蛋白溶解活性增强的研究。
J Clin Invest. 1959 May;38(5):810-22. doi: 10.1172/JCI103863.
7
Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.纤溶酶系统的研究。II. 血清或血浆对纤溶酶的抑制作用。
J Exp Med. 1958 Jul 1;108(1):53-68. doi: 10.1084/jem.108.1.53.
8
Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.昼夜纤维蛋白溶解节律的证据;采用一种测量自然纤维蛋白溶解的简单方法。
Clin Sci. 1957 Nov;16(4):645-50.

评估血浆或血清对尿激酶激活的纤维蛋白溶解抑制作用的方法。

Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis.

作者信息

Mann R D

出版信息

J Clin Pathol. 1966 May;19(3):233-7. doi: 10.1136/jcp.19.3.233.

DOI:10.1136/jcp.19.3.233
PMID:5937607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC473243/
Abstract

Activator concentration in the range 50 to 100 Ploug units urokinase is directly proportional to the reciprocal of the lysis time both in the presence and absence of the plasma or serum inhibitors. Inhibitory activity can be estimated, therefore, by the difference in lysis time between control clots containing a buffer or euglobulin component and plasma or serum containing clots both activated by a common concentration of urokinase selected from within the critical range. An experimental model for this purpose is described with an examination of the effects of each variable in this system and a reference curve in terms of a known inhibitor. In this study, it has been found that the effects of calcium are influenced by the plasminogen concentration and are biphasic in the presence of the serum inhibitors.

摘要

在存在和不存在血浆或血清抑制剂的情况下,浓度范围为50至100普洛格单位尿激酶的激活剂浓度与溶解时间的倒数成正比。因此,抑制活性可以通过含有缓冲液或优球蛋白成分的对照凝块与含有血浆或血清的凝块(两者均由选自临界范围内的常见浓度尿激酶激活)之间的溶解时间差异来估计。为此目的描述了一个实验模型,研究了该系统中每个变量的影响,并根据已知抑制剂绘制了参考曲线。在本研究中,发现钙的作用受纤溶酶原浓度的影响,并且在存在血清抑制剂的情况下呈双相性。